202 related articles for article (PubMed ID: 37561983)
1. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
[TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
[TBL] [Abstract][Full Text] [Related]
6. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status.
Castillo D; Yuan TA; Nehoray B; Cervantes A; Tsang KK; Yang K; Sand SR; Mokhnatkin J; Herzog J; Slavin TP; Hyman S; Schwartz A; Ebert BL; Amos CI; Garber JE; Weitzel JN
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1621-1629. PubMed ID: 35654360
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.
Jakubek YA; Reiner AP; Honigberg MC
Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227
[TBL] [Abstract][Full Text] [Related]
9. Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation.
Tague LK; Oetjen KA; Mahadev A; Walter MJ; Anthony H; Kreisel D; Link DC; Gelman AE
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 36853803
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
[TBL] [Abstract][Full Text] [Related]
11. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Truong H; Breen K; Nandakumar S; Sjoberg DD; Kemel Y; Mehta N; Lenis AT; Reisz PA; Carruthers J; Benfante N; Joseph V; Khurram A; Gopalan A; Fine SW; Reuter VE; Vickers AJ; Birsoy O; Liu Y; Walsh M; Latham A; Mandelker D; Stadler ZK; Pietzak E; Ehdaie B; Touijer KA; Laudone VP; Slovin SF; Autio KA; Danila DC; Rathkopf DE; Eastham JA; Chen Y; Morris MJ; Offit K; Solit DB; Scher HI; Abida W; Robson ME; Carlo MI
Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of liquid biopsy in cancer patients.
Chang CM; Lin KC; Hsiao NE; Hong WA; Lin CY; Liu TC; Chang YS; Chang JG
BMC Cancer; 2022 Apr; 22(1):413. PubMed ID: 35428225
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.
Ptashkin RN; Mandelker DL; Coombs CC; Bolton K; Yelskaya Z; Hyman DM; Solit DB; Baselga J; Arcila ME; Ladanyi M; Zhang L; Levine RL; Berger MF; Zehir A
JAMA Oncol; 2018 Nov; 4(11):1589-1593. PubMed ID: 29872864
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.
Hong W; Li A; Liu Y; Xiao X; Christiani DC; Hung RJ; McKay J; Field J; Amos CI; Cheng C
Cancer Res; 2022 Jan; 82(2):199-209. PubMed ID: 34815255
[TBL] [Abstract][Full Text] [Related]
17. Mutant
Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
[TBL] [Abstract][Full Text] [Related]
18. Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers.
Diplas BH; Ptashkin R; Chou JF; Sabwa S; Foote MB; Rousseau B; Argilés G; White JR; Stewart CM; Bolton K; Chalasani SB; Desai AM; Goldberg Z; Gu P; Li J; Shcherba M; Zervoudakis A; Cercek A; Yaeger R; Segal NH; Ilson DH; Ku GY; Zehir A; Capanu M; Janjigian YY; Diaz LA; Maron SB
JAMA Netw Open; 2023 Feb; 6(2):e2254221. PubMed ID: 36729457
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis and Risk of Incident Lung Cancer.
Tian R; Wiley B; Liu J; Zong X; Truong B; Zhao S; Uddin MM; Niroula A; Miller CA; Mukherjee S; Heiden BT; Luo J; Puri V; Kozower BD; Walter MJ; Ding L; Link DC; Amos CI; Ebert BL; Govindan R; Natarajan P; Bolton KL; Cao Y
J Clin Oncol; 2023 Mar; 41(7):1423-1433. PubMed ID: 36480766
[TBL] [Abstract][Full Text] [Related]
20. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
